Table 2.
Results of high NLR and low NLR mortality rates and cardiovascular events
| Outcomes | Included studies | Heterogeneity | Test for overall effect | ||||
|---|---|---|---|---|---|---|---|
| χ2 | P | I2(%) | Z | P | RR 95%CI | ||
| In-hospital | |||||||
| AHF | 19,20 | 1.54 | 0.22 | 35 | 5.81 | < 0.00001 | 1.81[1.48,2.21] |
| Angina | 14,20 | 0.08 | 0.78 | 0 | 2.71 | 0.007 | 1.67[1.15,2.41] |
| Arrhythmia | 8, 10,14,20 | 0.82 | 0.84 | 0 | 3.14 | 0.002 | 1.38[1.13,1.69] |
| In-stent thrombosis | 7,13 | 0.03 | 0.86 | 0 | 3.99 | < 0.0001 | 2.72[1.66,4.44] |
| MACE | 7,9,11,13,15,19 | 3.83 | 0.57 | 0 | 6.53 | < 0.00001 | 2.00[1.62,2.46] |
| Nonfatal MI | 7,9,13,19,20 | 4.88 | 0.30 | 18 | 4.32 | < 0.0001 | 1.93[1.43,2.61] |
| No reflow | 7,9,10,13,15,19 | 40.00 | < 0.00001 | 87 | 3.63 | 0.0003 | 2.28[1.46,3.57] |
| All mortality | 7,9,10,15,17,20 | 1.87 | 0.87 | 0 | 6.61 | < 0.00001 | 3.23[2.28,4.57] |
| Cardiac mortality | 10,13,14,16,19 | 1.77 | 0.78 | 0 | 6.42 | < 0.00001 | 3.22[2.25,4.60] |
| Long-term | |||||||
| Nonfatal MI | 9, 11,13,19, | 10.90 | 0.01 | 72 | 0.75 | 0.46 | 1.32[0.63,2.75] |
| MACE | 9,10,11,13,15,19 | 53.33 | < 0.00001 | 91 | 3.39 | 0.0007 | 2.49[1.47,4.23] |
| All mortality | 8,9,10,11,12,14,15 | 3.85 | 0.70 | 0 | 10.06 | < 0.00001 | 3.82[2.94,4.96] |
| Cardiac mortality | 10,13,16,18,19 | 43.78 | < 0.00001 | 91 | 2.85 | 0.004 | 3.02[1.41,6.45] |